Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Mar 9, 2018)
  • 8-K (Feb 8, 2018)
  • 8-K (Jan 17, 2018)
  • 8-K (Nov 13, 2017)
  • 8-K (Nov 6, 2017)
  • 8-K (Oct 4, 2017)

 
Other

Cardinal Health 8-K 2014

Documents found in this filing:

  1. 8-K
  2. 8-K
Sept 2014 8-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 9, 2014
 
Cardinal Health, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
 
 
 
Ohio
 
1-11373
 
31-0958666
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017
(Address of principal executive offices) (Zip Code)
(614) 757-5000
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(b) and (c)
On September 9, 2014, the Board of Directors of Cardinal Health, Inc. (the "Company") elected Michael C. Kaufmann Chief Financial Officer, effective November 11, 2014 (the "Effective Date"). Mr. Kaufmann will be the Company’s principal financial officer. Mr. Kaufmann has served as Chief Executive Officer, Pharmaceutical Segment since August 2009, and will be replaced in that role by Jon L. Giacomin, currently President, U.S. Pharmaceutical Distribution. In connection with his appointment to Chief Financial Officer, Mr. Kaufmann will receive a base salary of $700,000. He also will receive a grant of restricted share units on September 15, 2014 with a grant value of $3,000,000 that vests ratably over three years.
As previously reported, Jeffrey W. Henderson, the Company's current Chief Financial Officer, is retiring from the Company in August 2015. He will cease to serve as Chief Financial Officer on the Effective Date, but will remain an employee of the Company through his retirement date to ensure an orderly transition.

2





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
 
 
 
Cardinal Health, Inc.
(Registrant)
 
 
 
 
Date: September 11, 2014
 
 
 
By:
 
/s/ Stephen T. Falk
 
 
 
 
 
 
Name: Stephen T. Falk
 
 
 
 
 
 
Title: Executive Vice President, General Counsel and Corporate Secretary


3


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki